T hrombolysis with recombinant tissue plasminogen activator (rtPA) up to 4.5 hours of symptom onset is an established treatment for acute ischemic stroke. 1, 2 However, 8% to 27% of acute ischemic stroke patients, who wake up with neurological deficits, [3] [4] [5] [6] are not thrombolysed, even if they meet other clinical and imaging criteria for treatment, because onset time is unknown.
Circumstantial evidence suggests that selected patients with wake-up ischemic stroke (WUIS) may be a reasonable target for thrombolysis. Studies have shown that early structural and perfusion changes on computed tomography (CT) or MR imaging and intracranial large-vessel occlusions in WUIS patients are comparable with those with a known onset time and eligible for thrombolysis. [4] [5] [6] [7] [8] Studies suggest that thrombolysis with rtPA 9 or endovascular recanalization 10 may improve outcomes in patients with WUIS but are limited by small numbers and variability in outcome assessment.
We have recently shown a 5-fold increase in the likelihood of good functional outcomes at 90 days after adjusting for age, sex, and stroke severity in thrombolysed compared with matched nonthrombolysed WUIS patients with no or early ischemic changes on CT imaging.
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Another important question is whether outcomes of thrombolysed WUIS patients compare with those thrombolysed within 4.5 hours of stroke onset. A meta-analysis of 31 studies, including 11 816 stroke patients, showed an early-morning peak of ischemic stroke, 12, 13 suggesting that many of WUIS may occur within 4.5 hours of awakening. We hypothesized that thrombolysis outcomes in WUIS patients with no or early ischemic changes (EIC) on CT imaging will be comparable with acute ischemic stroke patients treated within 4.5 hours of stroke onset. We sampled an ongoing prospective stroke register to compare clinical outcomes and safety of thrombolysis in consecutive WUIS patients with consecutive ischemic stroke patients thrombolysed within 4.5 hours of stroke onset (Reference Group [RG] ).
Original Contribution
Background and Purpose-Wake-up ischemic stroke (WUIS) patients are not thrombolysed even if they meet other criteria for treatment. We hypothesized that patients with WUIS showing no or early ischemic changes on brain imaging will have thrombolysis outcomes comparable with those with known time of symptom onset. Methods-Consecutive sampling of a prospective registry of patients with stroke between January 2009 and December 2010 identified 394 thrombolysed patients meeting predefined inclusion criteria, 326 presenting within 0 to 4.5 hours of symptom onset (Reference Group) and 68 WUIS patients. Inclusion criteria were last seen normal <12 hours or >4.5 hours (WUIS) or presented <4.5 hours (Reference Group), had National Institutes of Health Stroke Scale score ≥5, and no or early ischemic changes on imaging at presentation. The primary outcome measure was the modified Rankin Scale of 0 to 2 at 90 days measured by trained assessors blinded to patient grouping. Other outcome measures were symptomatic intracerebral hemorrhage, modified Rankin Scale 0 to 1, and mortality at 90 days. 
Results-The

Methods
The methods for data collection have been described in detail previously. 11 To summarize, data on baseline clinical characteristics, stroke pathogenesis, and severity, times of stroke onset or last seen normal, arrival to hospital, imaging, and treatment were extracted from a prospective register of all stroke patients receiving thrombolysis at a tertiary comprehensive stroke center, serving a population of 500 000 between January 2009 and December 2010. The National Institutes of Health Stroke Scale (NIHSS) score at baseline and at 24 hours were assessed by certified assessors. All data extracted from the registry were verified against source data for completeness and accuracy. Standard dosage schedules for thrombolysis were followed, and patients were managed on the stroke intensive care unit after thrombolysis. The center offers thrombolysis with informed consent or relative assent to patients with WUIS as described previously. 11 This off-label use of rtPA was approved by the Novel Procedures and Therapeutics Committee. None of the patients with WUIS were treated with endovascular procedures. The study was approved by the Research Ethics Committee (11/EM/0190).
Imaging
All patients underwent routine noncontrast CT (NCCT) brain imaging, which was assessed for EIC using the Alberta Stroke Program Early CT Score (ASPECTS).
14 Thrombus in cerebral arteries and subtle EIC were further defined using reconstructed thin slices measuring 1.25 mm. 15 CT perfusion (CTP) imaging was not an obligatory requirement for thrombolysis and was undertaken immediately after NCCT in a proportion of patients by the treating physician. The threshold for core infarct was cerebral blood flow <10 mL/100 g per min and mean transit time>8 sec. The thresholds for potentially reversible ischemic tissue (penumbra) were cerebral blood flow 10 to 20 mL/100 g per min and mean transit time 4 to 8 seconds. Although the standard of care required thrombolysis decisions to be based on clinical and NCCT assessment only, CTP was undertaken immediately after NCCT in 63/122 (52%) of WUIS patients meeting NCCT criteria. A routine follow-up CT scan was performed at 24 hours after thrombolysis. Two trained investigators reassessed masked NCCT and CTP images for EIC and perfusion mismatch using ASPECTS and the semiquantitative ASPECTS-CTP methodology developed by Lin et al. 16 
Inclusion Criteria
Inclusion criteria were the following: (1) last seen normal <12 hours or >4.5 hours (WUIS) or presented <4.5 hours after symptom onset (RG); (2) no neurological deficits when last seen awake and witnessed persistent deficits on awakening (WUIS); (3) emergency presentation to hospital; (4) NIHSS score ≥5 on initial assessment; (5) no or EIC of <1/3 MCA territory on baseline CT scan; and (6) no absolute contraindications to rtPA use. Patients with NIHSS score <5 were not thrombolysed because the risk to benefit of thrombolysis for NIHSS <5 is equivocal in pooled data analyses.
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Outcomes
The primary outcome was the dichotomized mRS, defined as excellent (modified Rankin Scale [mRS], 0-1) or favorable (mRS, 0-2), and assessed at 90 days during a clinic visit or telephone by certified assessors not involved in patient care. Safety was assessed by mortality and the rate of symptomatic intracerebral hemorrhage (sICH) according to European Cooperative Acute Stroke Study-II classification.
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Statistics
All analyses were prespecified before data extraction. Data were tested using the Kolmogorov-Smirnov test and are presented as means (SD) or medians (interquartile range). Comparisons were undertaken using χ 2 test, Fisher exact test, independent samples t test, or Kruskal-Wallis test as appropriate.
Differences in the distribution of baseline prognostic variables between the 2 groups may be a source of inadvertent bias masking poor outcomes in patients with WUIS. Hence, potential predictors of outcome, including age, sex, vascular risk factors, baseline NIHSS score, ASPECTS, hyperdense artery sign, use of CTP, CTP mismatch, blood pressure, blood glucose, and door to needle time were entered into conditional logistic regression model with forward selection (inclusion P<0.1) to assess the independent associations between WUIS and the outcomes of mRS 0 to 1 at 90 days, mortality at 90 days, and sICH in the whole patient group (n=394). The model fit was by guest on July 13, 2017 http://stroke.ahajournals.org/ Downloaded from assessed using the Hosmer-Lemeshow test, and models with P>0.05 were discarded. Further comparisons of outcome between the WUIS and RG were performed after adjusting for age, stroke severity, and other independent predictors of outcome identified in these analyses. The distribution of mRS categories between WUIS and RG patients was compared using multivariate ordinal logistic regression analysis adjusted for age and baseline NIHSS score. Two-sided P<0.05 were considered significant. SPSS version 20.0 (IBM) was used for analyses.
Results
The criteria for WUIS was met by 170/1836 (9.3%) of the patients with ischemic stroke. Of these, 48 (28%) patients were ineligible for thrombolysis because last seen normal to presentation exceeded 12 hours (n=36) or the baseline NIHSS was <5 (n=12). A further 54 (32%) patients were not thrombolysed despite meeting criteria because they were unable to give consent or were unaccompanied by relative (n=26), refused consent (n=9), or treating physician decided against thrombolysis based on lack of mismatch on CTP imaging (n=19). Thrombolysis was undertaken in 68 patients with WUIS, 27 of whom did not show mismatch on CTP imaging. There were no differences in baseline characteristics, stroke severity, and NCCT imaging between thrombolysed (n=27) and nonthrombolysed (n=19) WUIS patients with no mismatch on CTP. Five (18%) of thrombolysed and 3 (16%) of nonthrombolysed with no mismatch had no new ischemic lesion (P=0.66). Thrombolysed patients with WUIS (n=68) were compared with 326 RG controls thrombolysed within 4.5 hours of stroke onset. Only 9/394 (2%) patients (all from RG) were lost to follow-up at 90 days. Table 1 describes the baseline clinical and imaging data. Both groups were comparable for age, vascular risk profile, and baseline blood pressure, blood glucose, the extent of EIC, and frequency of hyperdense arteries. The use of CT perfusion was significantly greater in patients with WUIS. The door to scan time was comparable between the 2 groups, but the median door to needle time was 13 minutes longer in patients with WUIS. There were no differences in early improvements, functional outcomes at 90 days, and intracranial hemorrhage rates between the 2 groups (Table 1) . Thrombolysis was associated with a shift toward better outcomes in patients with WUIS (Figure) . Causes of death in patients with WUIS included sICH (n=1), cerebral edema (n=1), and large infarct with secondary complications (n=8).
The comparability of outcomes in thrombolysed patients with WUIS to a standard of care RG was evaluated by reanalyzing data limited to patients meeting the European Cooperative Acute Stroke Study-III criteria. 19 This analysis included 197 patients in the RG and 33 patients in the WUIS group ( Table 2) . The reasons for exclusion of patients with WUIS were the following: age >80 years (n= 27), NIHSS score >25 (n=3), other (n=5). Baseline clinical and radiological characteristics were comparable between RG and WUIS, with >50% patients achieving favorable outcomes (mRS, 0-2) at 90 days. Patients with WUIS showed lower mortality and sICH rates with greater shift to a better mRS category at 90 days (Figure) .
Independent predictors of mortality on logistic regression were the following: age (OR 
057).
There were no differences in outcome of thrombolysis between patients with WUIS and the RG even after adjusting for these variables ( Table 3) .
The significantly greater use of CTP imaging in WUIS patients may have led to a selection bias favoring good outcomes. 20 Hence, outcomes were compared between WUIS and RG patients thrombolysed without CTP imaging and in patients with WUIS showing no matched or mismatched deficits (Table 4 ). There were no differences in the proportion of patients achieving good outcomes at 3 months, mortality or bleeding complications between patients with WUIS and RG thrombolysed on the basis of NCCT alone. A significant difference in functional outcomes or sICH rates was not seen between patients with WUIS with no or matched deficits and those with mismatch (Table 4 ). 
Discussion
This retrospective analysis of data in thrombolysed consecutive acute ischemic stroke patients shows no significant differences in mortality, functional outcomes, or bleeding rates between WUIS patients with no or EIC on CT and those treated within 4.5 hours of stroke onset. The comparability of outcomes persisted even after adjusting for age, sex, diabetes mellitus, atrial fibrillation, stroke pathogenesis, blood pressure, blood glucose, baseline NIHSS score, CTP use or mismatch in logistical models. WUIS is relatively common, [3] [4] [5] [6] and thrombolysis in these patients may be associated with better outcomes. [9] [10] [11] Outcomes similar to those thrombolysed within 3 h of stroke onset were reported in an observational study, 9 but only 28/46 patients with WUIS received IV rtPA, and outcomes were measured at discharge rather than at 90 days. Partial-to-complete recanalization was seen in 20/30 (67%) patients treated with endovascular procedures >8 hours after symptom onset (some WUIS), but only 6 (20%) patients achieved mRS score of 0 to 2 at 90 days. 10 A small RCT using CTP selection in 12 patients with unknown time of onset (9 WUIS) showed reperfusion in 4/6 of thrombolysed patients compared with 1/5 in the control group. 21 Do outcomes in patients with WUIS compare more widely with registry outcome data for patients thrombolysed within 4.5 hours of stroke onset? The mean age of 73 years and the baseline median NIHSS score of 13 of patients with WUIS were similar to large registries, 22-25 but a higher proportion of patients with WUIS in this and the other WUIS study 9 had ASPECTS of 8 to 10 (80% to 90% versus 60%) compared with patients included in registries. 22 Both this and the previous study 9 showed that the proportion of patients with WUIS with excellent or favorable outcomes was not different from patients thrombolysed within 4.5 hours of stroke onset, 2, 23, 24 nor was there an excess of sICH rates compared with registry data. 23 These similarities in presentation, imaging, and outcomes support the possibility that many WUIS strokes occur within 4.5 hours of awakening and are suitable target for thrombolysis.
Limitations in using clinical registry data include bias in patient selection, recording, and completeness of data and assessments of outcome. Patient selection bias was minimized by predefining patient selection criteria and including all consecutive patients meeting inclusion criteria. Registry data were collected prospectively, and standardized definitions/scales were used to assess baseline characteristics, stroke severity, and outcomes. Data were verified against medical records and source images were reviewed by trained physicians unaware of patient group at the time of analysis. Outcomes were assessed by certified observers not involved in direct patient care. Data analyses were prespecified, and only 9/394 (2%) patients were lost to follow-up at 90 days. The more frequent use of CTP in patients with WUIS is another source of bias favoring good outcomes in this group. Recent studies suggest that perfusion mismatch-based thrombolysis is associated with good clinical outcomes, even up to 12 hours from stroke onset. 26 We did not find any such association in this study, probably because of small numbers of patients undergoing CTP, arbitrary physician-led criteria for perfusion imaging, and limitations of techniques used to assess perfusion mismatch. 27 Despite comparability of baseline data, the effect of bedside bias because of clinical judgment in case selection cannot be excluded. This is particularly evident by the randomness of thrombolysis decisions made by treating physicians in patients with WUIS who did not show a mismatch on CTP but met clinical and NCCT criteria for treatment. These limitations highlight the importance of prospective multicenter randomized controlled studies and recruitment of patients with WUIS into ongoing trials. 
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